Doppler Myocardial Imaging Compared to Standard Two-Dimensional and Doppler Echocardiography for Assessment of Diastolic Function in Patients With Systemic Amyloidosis

Journal of the American Society of Echocardiography

Volumn 22, Issue 3, 2009, Pages 290-298

  Al Zahrani, Ghormallah B ^a   Bellavia, Diego ^a   Pellikka, Patricia A ^a   Dispenzieri, Angela ^a   Hayman, Suzanne R ^a   Oh, Jae K ^a   Miyazaki, Chinami ^a   Miller Jr , Fletcher A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cardiac amyloidosis; Diastolic dysfunction; Doppler myocardial imaging; Doppler tissue imaging; Restrictive cardiomyopathy; Strain rate imaging; Velocity imaging

Indexed keywords

ADULT; AGED; AMYLOIDOSIS; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PULSE WAVE; TISSUE DOPPLER IMAGING; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AMYLOIDOSIS; ECHOCARDIOGRAPHY, DOPPLER; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 60849108898     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.echo.2008.11.013     Document Type: Article

References (15)

1. Klein A.L., Hatle L.K., Burstow D.J., Seward J.B., Kyle R.A., Bailey K.R., et al. Doppler characterization of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol 13 (1989) 1017-1026
2. Klein A.L., Hatle L.K., Taliercio C.P., Taylor C.L., Kyle R.A., Bailey K.R., et al. Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol 16 (1990) 1135-1141
3. Klein A.L., Hatle L.K., Taliercio C.P., Oh J.K., Kyle R.A., Gertz M.A., et al. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study. Circulation 83 (1991) 808-816
4. Koyama J., Ray-Sequin P.A., and Falk R.H. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation 107 (2003) 2446-2452
5. Bellavia D., Abraham T.P., Pellikka P.A., Al-Zahrani G.B., Dispenzieri A., Oh J.K., et al. Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography. J Am Soc Echocardiogr 20 (2007) 1194-1202
6. Skinner M., Sanchorawala V., Seldin D.C., Dember L.M., Falk R.H., Berk J.L., et al. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med 140 (2004) 85-93
7. Gertz M.A., Lacy M.Q., Lust J.A., Greipp P.R., Witzig T.E., and Kyle R.A. Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis. Am J Hematol 61 (1999) 115-119
8. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
9. Gilman G., Khandheria B.K., Hagen M.E., Abraham T.P., Seward J.B., and Belohlavek M. Strain rate and strain: a step-by-step approach to image and data acquisition. J Am Soc Echocardiogr 17 (2004) 1011-1020
10. Brennan P. Statistical methods for assessing observer variability in clinical measures. SA. BMJ 304 (1992) 1491-1494
11. Comenzo R.L., Vosburgh E., Simms R.W., Bergethon P., Sarnacki D., Finn K., et al. Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients. Blood 88 (1996) 2801-2806
12. Dispenzieri A., Lacy M.Q., Zeldenrust S.R., Hayman S.R., Kumar S.K., Geyer S.M., et al. The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis. Blood 109 (2007) 465-470
13. Modesto K.M., Cauduro S., Dispenzieri A., Khandheria B., Belohlavek M., Lysyansky P., et al. Two-dimensional acoustic pattern derived strain parameters closely correlate with one-dimensional tissue Doppler derived strain measurements. Eur J Echocardiogr 7 (2006) 315-321
14. Liao R., Jain M., Teller P., Connors L.H., Ngoy S., Skinner M., et al. Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts. Circulation 104 (2001) 1594-1597
15. Brenner D.A., Jain M., Pimentel D.R., Wang B., Connors L.H., Skinner M., et al. Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. Circ Res 94 (2004) 1008-1010